Eiko Lifesciences has entered into a Share Subscription Agreement (SSA) with Reflux Pharmaceuticals (RPPL) in connection with the acquisition of up to 19,20,000 Equity Shares being 25.01% Equity stake in RPPL in one or more tranches for a consideration of Rs 7.00 crore.
The said partnership with RPPL would benefit the company in co-developing, marketing and sourcing key Active Pharma Ingredients (APIs) and Speciality Chemicals products. Also, this partnership will help the Company to set its footprints in various Geographic areas.
Reflux Pharmaceuticals is a private limited company involved in the manufacturing and marketing of its own Active Pharmaceutical ingredients and Intermediates (APIs). The various products manufactured by RPPL are Tolfenamic Acid, Flavoxate HCI, Diacerein, Albendazole, Carprofen, Sulindac etc.
Eiko LifeSciences is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and Globally.
Company Name | CMP |
---|---|
Tata Chemicals | 1046.80 |
SRF | 2259.95 |
Pidilite Inds. | 2911.00 |
Aarti Inds | 411.35 |
Atul | 7062.05 |
View more.. |